Diluted EPS came in at $-3.81, missed the $-1.96 consensus by $1.85.
Trailing eight quarters through Q2 2024
Common questions about Tectonic Therapeutics's Q2 2024 earnings report.
Tectonic Therapeutics (TECX) reported Q2 2024 earnings on August 14, 2024 before market open.
Tectonic Therapeutics reported diluted EPS of $-3.81 for Q2 2024.
EPS missed the consensus estimate of $-1.96 by $1.85.
You can read the 10-Q periodic report (0001193125-24-200609) directly on SEC EDGAR. The filing index links above go to sec.gov.